Healthcare Analytical Testing Services Market Expected To Grow With USD 23.9 Billion By 2028
San Francisco, 9 April 2021: The Report Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Product Type (Medical Device, Pharmaceutical), By Region (APAC, North America), And Segment Forecasts, 2021 - 2028 The global healthcare analytical testing services market size is expected to reach USD 23.9 billion by 2028 at a CAGR of 9.8% over the forecast period, according to a new report by Grand View Research, Inc. Growing emphasis on biosimilars, increased outsourcing of the aforementioned services by pharmaceutical companies, and rise in the number of clinical trials are some of the key factors expected to drive the global market in the years to come. Biosimilars are FDA-approved treatments and possess highly identical properties to approved biologic drugs. They serve as a low-cost and effective treatment option when compared to biologics, which is anticipated to increase its demand remarkably in the coming years. An article on biosimilars publi